Related Experiment Video

Updated: Jun 14, 2026

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

Quantitative evaluation of a clinical intervention aimed at changing prescriber behaviour in response to new

Sophie Doyon1, Mélissa Perreault, Christopher Marquis

  • 1Department of Pharmacy and Research Unit of Pharmacy Practice, CHU Sainte-Justine, Montreal, QC, Canada.

Journal of Evaluation in Clinical Practice
|April 7, 2010
PubMed

Insights

Disseminating acute community-acquired pneumonia guidelines significantly improved prescriber compliance by over 30% in a pediatric hospital. This led to more appropriate antibiotic selection, enhancing patient care.

Area of Science:

  • Pediatric Medicine
  • Infectious Diseases
  • Healthcare Quality Improvement

Background:

  • Acute community-acquired pneumonia (CAP) requires adherence to evidence-based guidelines for optimal management.
  • Prescriber compliance with CAP management guidelines can vary significantly in clinical practice.
  • Assessing and improving guideline adherence is crucial for enhancing pediatric patient outcomes.

Purpose of the Study:

  • To evaluate the impact of disseminating new CAP management guidelines on prescriber compliance.
  • To compare prescriber adherence rates before and after guideline implementation in a pediatric hospital.
  • To identify specific areas of non-compliance, such as antibiotic selection, and assess improvements.

Main Methods:

  • A quasi-experimental study design was employed in a tertiary care pediatric hospital.
  • Prescriber compliance was assessed using a compliance score before and after guideline dissemination.
  • The intervention involved peer leader consultation, networking, guideline distribution, and educational sessions.

Main Results:

  • Prescriber compliance with CAP guidelines increased from 20.1% pre-intervention to 52.9% post-intervention, a 32.8% improvement.
  • Inappropriate antibiotic selection, a major cause of non-compliance, decreased from 66.6% to 42.1%.
  • Improved compliance was observed in both the emergency department and hospital wards.

Conclusions:

  • Guideline dissemination for CAP management significantly enhanced prescriber compliance.
  • The intervention effectively improved antibiotic prescribing practices for pediatric CAP.
  • These findings support the implementation of guideline dissemination strategies to improve clinical care quality.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Nursing Evaluation01:15

Nursing Evaluation

The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...